Literature DB >> 8028330

Inhibition of neutrophil leukotriene generation by the 21-aminosteroid, U-74389F.

D Gadaleta1, M Verma, J M Davis.   

Abstract

The 21-aminosteroids are potent inhibitors of iron-dependent lipid peroxidation and more protective than methylprednisolone in models of trauma and reperfusion, but without glucocorticosteroid side effects. Histologically, animals treated with 21-aminosteroids have decreased neutrophil (PMN) infiltrates and diminished tissue destruction associated with trauma or reperfusion. Since PMN contribute to organ failure following ischemia-reperfusion, we assessed the effect of U-74389F (U7), on normal PMN function. Neutrophils from normal volunteers were incubated for 90 min with either vehicle, 15 microM U7 or 80 microM methylprednisolone (MP), in DMSO. Lactoferrin released and generation of leukotrienes to calcium ionophore A23187, also oxygen consumed to PMA and leukotriene B4 (LTB4) and chemotaxis to FMLP and LTB4, were determined for each group of PMN. Lactoferrin released to A23187 was significantly decreased in both steroid groups (7.29 +/- 0.82 micrograms vs 3.06 +/- 0.57 micrograms U7 and 2.88 +/- 0.62 micrograms MP, P < 0.01). PMN incubated with U7 or MP generated significantly less LTB4 (60.6 +/- 4.3 ng vs 47.7 +/- 2.4 ng U7 and 43.3 +/- 5.6 ng MP, P < 0.05). There were no differences noted in the ability of PMN incubated with either compound to consume oxygen or to respond to chemotactic stimuli. We conclude that the proven protective action of the 21-aminosteroids in models of ischemia-reperfusion is related to the ability of "steroids" to inhibit leukotriene generation and degranulation and may be related to the prevention of tissue lipid peroxidation by scavenging oxygen radicals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8028330     DOI: 10.1006/jsre.1994.1137

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Effects of allopurinol and steroids on inflammation and oxidative tissue damage in experimental lens induced uveitis: a biochemical and morphological study.

Authors:  A J Augustin; M Spitznas; W Sekundo; F Koch; J Lutz; D Meller; F H Grus; A Wegener; S H Blumenröder
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

2.  Comparison of various lazaroid compounds for protection against ischemic liver injury.

Authors:  N Ishizaki; Y Zhu; S Zhang; A Nemoto; Y Kobayashi; V M Subbotin; R G Lee; T E Starzl; S Todo
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

3.  The effects of lazaroid U-74389G in a rat sepsis model.

Authors:  Yun-Te Chang; Shue-Ren Wann; Kai-Hseng Hsieh; Yung-Ching Liu; Ching-Hsiung Chang; Mu-Shun Huang; Chun-I Huang; Hong-Tai Chang
Journal:  Inflamm Res       Date:  2010-07-11       Impact factor: 4.575

4.  Lazaroid U-74500A for warm ischemia and reperfusion injury of the canine small intestine.

Authors:  H Tanaka; Y Zhu; S Zhang; N Ishizaki; M B Jin; T Azuma; R Lee; T E Starzl; S Todo
Journal:  J Am Coll Surg       Date:  1997-04       Impact factor: 6.113

5.  21-aminosteroids prevent the down-regulation of hepatic cytochrome P450 induced by hypoxia and inflammation in conscious rabbits.

Authors:  A Galal; P Souich
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

6.  Lazaroid U-74389G for 48-hour canine liver preservation.

Authors:  S Todo; N Hamada; Y Zhu; S Zhang; V Subbotin; A Nemoto; I Takeyoshi; T E Starzl
Journal:  Transplantation       Date:  1996-01-27       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.